Broncus Holding Corporation
BRNHF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$149.88M
Close$
$0.06
78.9% downside
Current Fair Value
78.9% downsideOvervalued by 78.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $149.88 Million |
|---|---|
| Enterprise Value | $129.50 Million |
| Earnings per Share | $-0.04 |
| Beta | 1.19 |
| Outstanding Shares | 488,217,595 |
Return
| Return on Equity | -23.36% |
|---|---|
| Return on Assets | -22.16% |
| Return on Invested Capital | -31.04% |
Valuation & Multiples
| P/E Ratio | -1.98 |
|---|---|
| PEG | -48.37 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 16.43 |
| Enterprise Value to EBIT | -2.91 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
March 31, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Broncus Holding Corporation
195 employees
CEO: Hong Xu
Broncus Holding Corporation is a global medical technology company specializing in the development of interventional pulmonology products. Its market reach extends across Mainland China, the European Union, the United States, and other i...